The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Lung Cancer Surgery-Global Market Insights and Sales Trends 2024
Synopsis
Lung adenocarcinoma is a type of lung cancer and belongs to non-small cell carcinoma.
The global Lung Cancer Surgery market size is expected to reach US$ 30200 million by 2029, growing at a CAGR of 5.4% from 2023 to 2029. The market is mainly driven by the significant applications of Lung Cancer Surgery in various end use industries. The expanding demands from the Lobectomy, Removal Of Sleeve, Regional Excision and Lung Removed All, are propelling Lung Cancer Surgery market. Surgical Instruments, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Monitoring And Visualization System segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Lung Cancer Surgery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Lung Cancer Surgery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Lung Cancer Surgery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Lung Cancer Surgery sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Lung Cancer Surgery covered in this report include Accuray, Angiodynamics, Ethicon, Intuitive Surgical, Olympus, Teleflex, Ackermann Instrumente, Karl Storz and Scanlan International, etc.
The global Lung Cancer Surgery market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Accuray
Angiodynamics
Ethicon
Intuitive Surgical
Olympus
Teleflex
Ackermann Instrumente
Karl Storz
Scanlan International
Trokamed
Global Lung Cancer Surgery market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Lung Cancer Surgery market, Segment by Type:
Surgical Instruments
Monitoring And Visualization System
Global Lung Cancer Surgery market, by Application
Lobectomy
Removal Of Sleeve
Regional Excision
Lung Removed All
Minimally Invasive Surgery
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Lung Cancer Surgery companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Lung adenocarcinoma is a type of lung cancer and belongs to non-small cell carcinoma.
The global Lung Cancer Surgery market size is expected to reach US$ 30200 million by 2029, growing at a CAGR of 5.4% from 2023 to 2029. The market is mainly driven by the significant applications of Lung Cancer Surgery in various end use industries. The expanding demands from the Lobectomy, Removal Of Sleeve, Regional Excision and Lung Removed All, are propelling Lung Cancer Surgery market. Surgical Instruments, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Monitoring And Visualization System segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Lung Cancer Surgery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Lung Cancer Surgery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Lung Cancer Surgery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Lung Cancer Surgery sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Lung Cancer Surgery covered in this report include Accuray, Angiodynamics, Ethicon, Intuitive Surgical, Olympus, Teleflex, Ackermann Instrumente, Karl Storz and Scanlan International, etc.
The global Lung Cancer Surgery market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Accuray
Angiodynamics
Ethicon
Intuitive Surgical
Olympus
Teleflex
Ackermann Instrumente
Karl Storz
Scanlan International
Trokamed
Global Lung Cancer Surgery market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Lung Cancer Surgery market, Segment by Type:
Surgical Instruments
Monitoring And Visualization System
Global Lung Cancer Surgery market, by Application
Lobectomy
Removal Of Sleeve
Regional Excision
Lung Removed All
Minimally Invasive Surgery
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Lung Cancer Surgery companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Lung Cancer Surgery
1.1 Lung Cancer Surgery Market Overview
1.1.1 Lung Cancer Surgery Product Scope
1.1.2 Lung Cancer Surgery Market Status and Outlook
1.2 Global Lung Cancer Surgery Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Lung Cancer Surgery Market Size by Region (2018-2029)
1.4 Global Lung Cancer Surgery Historic Market Size by Region (2018-2023)
1.5 Global Lung Cancer Surgery Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Lung Cancer Surgery Market Size (2018-2029)
1.6.1 North America Lung Cancer Surgery Market Size (2018-2029)
1.6.2 Europe Lung Cancer Surgery Market Size (2018-2029)
1.6.3 Asia-Pacific Lung Cancer Surgery Market Size (2018-2029)
1.6.4 Latin America Lung Cancer Surgery Market Size (2018-2029)
1.6.5 Middle East & Africa Lung Cancer Surgery Market Size (2018-2029)
2 Lung Cancer Surgery Market by Type
2.1 Introduction
2.1.1 Surgical Instruments
2.1.2 Monitoring And Visualization System
2.2 Global Lung Cancer Surgery Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Lung Cancer Surgery Historic Market Size by Type (2018-2023)
2.2.2 Global Lung Cancer Surgery Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Lung Cancer Surgery Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Lung Cancer Surgery Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Lung Cancer Surgery Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Lung Cancer Surgery Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Lung Cancer Surgery Revenue Breakdown by Type (2018-2029)
3 Lung Cancer Surgery Market Overview by Application
3.1 Introduction
3.1.1 Lobectomy
3.1.2 Removal Of Sleeve
3.1.3 Regional Excision
3.1.4 Lung Removed All
3.1.5 Minimally Invasive Surgery
3.2 Global Lung Cancer Surgery Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Lung Cancer Surgery Historic Market Size by Application (2018-2023)
3.2.2 Global Lung Cancer Surgery Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Lung Cancer Surgery Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Lung Cancer Surgery Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Lung Cancer Surgery Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Lung Cancer Surgery Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Lung Cancer Surgery Revenue Breakdown by Application (2018-2029)
4 Lung Cancer Surgery Competition Analysis by Players
4.1 Global Lung Cancer Surgery Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lung Cancer Surgery as of 2022)
4.3 Date of Key Players Enter into Lung Cancer Surgery Market
4.4 Global Top Players Lung Cancer Surgery Headquarters and Area Served
4.5 Key Players Lung Cancer Surgery Product Solution and Service
4.6 Competitive Status
4.6.1 Lung Cancer Surgery Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Accuray
5.1.1 Accuray Profile
5.1.2 Accuray Main Business
5.1.3 Accuray Lung Cancer Surgery Products, Services and Solutions
5.1.4 Accuray Lung Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.1.5 Accuray Recent Developments
5.2 Angiodynamics
5.2.1 Angiodynamics Profile
5.2.2 Angiodynamics Main Business
5.2.3 Angiodynamics Lung Cancer Surgery Products, Services and Solutions
5.2.4 Angiodynamics Lung Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.2.5 Angiodynamics Recent Developments
5.3 Ethicon
5.3.1 Ethicon Profile
5.3.2 Ethicon Main Business
5.3.3 Ethicon Lung Cancer Surgery Products, Services and Solutions
5.3.4 Ethicon Lung Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.3.5 Intuitive Surgical Recent Developments
5.4 Intuitive Surgical
5.4.1 Intuitive Surgical Profile
5.4.2 Intuitive Surgical Main Business
5.4.3 Intuitive Surgical Lung Cancer Surgery Products, Services and Solutions
5.4.4 Intuitive Surgical Lung Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.4.5 Intuitive Surgical Recent Developments
5.5 Olympus
5.5.1 Olympus Profile
5.5.2 Olympus Main Business
5.5.3 Olympus Lung Cancer Surgery Products, Services and Solutions
5.5.4 Olympus Lung Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.5.5 Olympus Recent Developments
5.6 Teleflex
5.6.1 Teleflex Profile
5.6.2 Teleflex Main Business
5.6.3 Teleflex Lung Cancer Surgery Products, Services and Solutions
5.6.4 Teleflex Lung Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.6.5 Teleflex Recent Developments
5.7 Ackermann Instrumente
5.7.1 Ackermann Instrumente Profile
5.7.2 Ackermann Instrumente Main Business
5.7.3 Ackermann Instrumente Lung Cancer Surgery Products, Services and Solutions
5.7.4 Ackermann Instrumente Lung Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.7.5 Ackermann Instrumente Recent Developments
5.8 Karl Storz
5.8.1 Karl Storz Profile
5.8.2 Karl Storz Main Business
5.8.3 Karl Storz Lung Cancer Surgery Products, Services and Solutions
5.8.4 Karl Storz Lung Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.8.5 Karl Storz Recent Developments
5.9 Scanlan International
5.9.1 Scanlan International Profile
5.9.2 Scanlan International Main Business
5.9.3 Scanlan International Lung Cancer Surgery Products, Services and Solutions
5.9.4 Scanlan International Lung Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.9.5 Scanlan International Recent Developments
5.10 Trokamed
5.10.1 Trokamed Profile
5.10.2 Trokamed Main Business
5.10.3 Trokamed Lung Cancer Surgery Products, Services and Solutions
5.10.4 Trokamed Lung Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.10.5 Trokamed Recent Developments
6 North America
6.1 North America Lung Cancer Surgery Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Lung Cancer Surgery Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Lung Cancer Surgery Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Lung Cancer Surgery Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Lung Cancer Surgery Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Lung Cancer Surgery Market Dynamics
11.1 Lung Cancer Surgery Industry Trends
11.2 Lung Cancer Surgery Market Drivers
11.3 Lung Cancer Surgery Market Challenges
11.4 Lung Cancer Surgery Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
